anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Fusion Pharmaceuticals · pitchdeck

Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides

49 pages · 5 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides

Fusion Pharmaceuticals · 2020-06
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 22 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides · 2 hits 100% 1/1 slides Solution 6 slides 100% 6/6 slides 100% 6/6 slides · 27 hits
— 0/6 slides
16.7% 1/6 slides 66.7% 4/6 slides 100% 6/6 slides
— 0/6 slides
Traction 10 slides 100% 10/10 slides 100% 10/10 slides · 49 hits
— 0/10 slides
40% 4/10 slides · 5 hits 20% 2/10 slides 100% 10/10 slides · 11 hits 60% 6/10 slides Roadmap 4 slides 100% 4/4 slides 100% 4/4 slides · 17 hits
— 0/4 slides
50% 2/4 slides 50% 2/4 slides 100% 4/4 slides
— 0/4 slides
Team 1 slides 100% 1/1 slides 100% 1/1 slides · 7 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

49
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
analyze_data
Open slide detail
03
other
Open slide detail
04
transition
Open slide detail
05
The slide uses a grid layout to display five executives with their headshots, titles, and logos of past organizations.other
Open slide detailBeat · Team
06
The slide uses a bulleted list to highlight key competitive advantages and strategic positioning.summarize
Open slide detail
07
The slide uses a three-stage process flow to illustrate the company's origin story and market positioning.plan_implementation
Open slide detail
08
Uses a two-part visual comparison: physical properties vs. therapeutic mechanism.establish_context
Open slide detail
09
The slide uses a process flow to explain the mechanism of action for Targeted Alpha Therapy (TAT).present_solution
Open slide detailBeat · Solution
10
The slide uses a process diagram to explain the therapeutic mechanism of Ac-225 based radiopharmaceuticals.present_solution
Open slide detailBeat · Solution
11
Includes a biological process diagram and a line chart comparing excretion rates.present_solution
Open slide detailBeat · Solution
12
The slide uses a funnel diagram to illustrate the R&D process from molecule leads to efficacy studies, followed by a process flow showing the impact of the linkpresent_solution
Open slide detailBeat · Solution
13
The slide illustrates a process flow from the imaging analogue to the clinical outcomes of population enrichment and organ safety assessment.present_solution
Open slide detailBeat · Solution
14
The slide uses a value-chain style flow to demonstrate operational maturity and competitive moat.present_solution
Open slide detailBeat · Solution
15
The slide uses a standard pharmaceutical pipeline visualization format.plan_implementation
Open slide detailBeat · Roadmap
16
The slide functions as a hybrid team bio and program introduction slide.other
Open slide detailBeat · Roadmap
17
Includes a PET scan image demonstrating targeted tumor uptake vs normal tissue.present_solution
Open slide detailBeat · Roadmap
18
Uses a funnel diagram to illustrate the R&D process steps.present_solution
Open slide detailBeat · Roadmap
19
The slide compares tumor volume growth curves (left) with histological H&E staining results (right) to demonstrate efficacy.show_traction
Open slide detailBeat · Traction
20
The slide uses three distinct charts (two line graphs for different tumor types, one for large tumors) and a microscopy image to demonstrate therapeutic efficacshow_traction
Open slide detailBeat · Traction
21
summarize
Open slide detailBeat · Traction
22
Includes headshot of James O'Leary, MD.transition
Open slide detailBeat · Traction
23
The slide uses a human body diagram to visually represent the systemic nature of the target.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
24
Includes specific DLT observation period assumptions and context regarding COVID-19 trial interruptions.plan_implementation
Open slide detailBeat · TractionLoop · Cost Of Inaction
25
The slide uses medical imaging to validate the efficacy of the therapeutic agent in diverse solid tumor environments.show_traction
Open slide detailBeat · TractionLoop · Cost Of Inaction
26
The slide demonstrates the stability of the drug's targeting mechanism over time, which is critical for multi-dose therapeutic regimens.show_traction
Open slide detailBeat · TractionLoop · Cost Of Inaction
27
The slide uses a medical/scientific aesthetic with an atom-like graphic overlay.summarize
Open slide detailBeat · TractionLoop · Cost Of Inaction
28
The chart shows individual patient data points grouped by organ and cohort, with a clear 'Limit' bar for each organ.analyze_data
Open slide detailBeat · TractionLoop · Cost Of Inaction
29
transition
Open slide detail
30
The slide uses a dual-panel approach to illustrate two distinct mechanisms of action for combination therapy.present_solution
Open slide detail
31
The slide uses a standard preclinical study design (process flow) followed by two line charts comparing treatment efficacy.show_traction
Open slide detail
32
The slide uses a process diagram to explain the experimental design (re-challenge model) followed by a line chart showing tumor volume over time.show_traction
Open slide detail
33
The slide demonstrates the mechanism of action for the therapeutic effect, specifically highlighting T cell memory.show_traction
Open slide detail
34
The chart demonstrates synergistic efficacy in a tumor xenograft model.present_solution
Open slide detail
35
plan_implementation
Open slide detail
36
front_matter
Open slide detailLoop · Quick Win Big Bet
37
The slide uses a three-column layout to categorize R&D and business development activities.plan_implementation
Open slide detailLoop · Quick Win Big Bet
38
The slide uses a comparative structure (Rationale vs. Approach) to justify the development of a specific therapeutic candidate.present_solution
Open slide detailLoop · Quick Win Big Bet
39
transition
Open slide detailLoop · Quick Win Big Bet
40
Includes footnotes explaining the Series B tranche structure and pro forma cash calculation.show_traction
Open slide detailLoop · Quick Win Big Bet
41
The slide uses a table format to communicate project timelines.plan_implementation
Open slide detailLoop · Quick Win Big Bet
42
summarize
Open slide detail
43
summarize
Open slide detail
44
state_next_steps
Open slide detail
45
appendix
Open slide detail
46
The slide lists specific patent numbers and filing dates for various programs including IGF-1R, linker platforms, and radioimmunoconjugates.other
Open slide detail
47
The slide uses a table to contrast physical properties and a medical imaging sequence to demonstrate clinical efficacy.compare_peers
Open slide detail
48
Includes inclusion criteria and specific dosimetry constraints.plan_implementation
Open slide detail
49
Clinical trial safety data presentation.analyze_data
Open slide detail